Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy

NCT00329381 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Xolair
DRUG: Xolair

Sponsor

University of Mississippi Medical Center

Collaborators

[object Object]